This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With this acquisition, Gerresheimer strengthens its European footprint with additional production sites and underpins its market position as a leading full-service provider and global partner for the pharma and biotech industries. Gerresheimer expects the acquisition to be accretive to the Group’s Adj. EBITDA margin and Adj.
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. Financial details of the acquisition are not being disclosed.
Chairman of the UAE’s IBC Group is working with the UK biotech research company, Vaxbio to launch an affordable vaccine that the company hopes to launch by the summer.
Whether they are digital health, medical device, biotech, or pharma companies, healthtech has costly and inefficient sales processes that often stem from a lack of foundational data & insights to reach the right target markets efficiently and effectively. physicians, physician groups, hospitals, health systems, etc).
Biotech Showcase is true to its name – great companies are highlighted.” Tina Elder, Global Managing Director, EBD Group US, said, “Biotech Showcase has once again shown itself to be the premiere destination for innovators and partners to access a powerful network of industry decision-makers, media and top investors.
The health/care ecosystem continues to morph as the stakeholder groups themselves are blurring across and outside of their core businesses. Today’s example of this is Clover Health, which launched Clover Therapeutics this week.
–(BUSINESS WIRE)– Supreme Group , backed by growth-oriented private equity firm Trinity Hunt Partners , today announced it has acquired Health+Commerce , an integrated agency providing strategic public relations, marketing, and creative services to innovative healthcare companies. For more information, visit www.trinityhunt.com.
“The future of wellness is a move from lonely to social self-care,” Beth writes, “buying to belonging, URL to IRL, ego to empathy, Goop to group.” Being Missourian in spirit and intent: seeking the science and the evidence.
This activity sent pharma and biotech companies scrambling to hire DE&I officers and related patient advocacy, engagement, and experience personnel as they came to terms with this foreign notion of actually collaborating with real, live patients. She is currently contracted by Parexel as their first Patient Ambassador.
Today’s announcement comes following the October 2023 acquisition of Healthware Group , an agency and innovation consultancy headquartered in Salerno, Italy. The new affiliate will operate from multiple offices across Italy, Finland, the United Kingdom and the United States, focused on innovation, transformation and client delight.
Claudia Pingue, senior partner and head of the Technology Transfer Fund of CDP Venture Capital SGR , added: “Aptadir is the first biotech company born from EXTEND, National Technology Transfer hub established on the initiative of CDP Venture Capital and funded with co-investment partners, Angelini Ventures and Evotec.
–(BUSINESS WIRE)– #Biotech –Taking a people-first approach, BioscienceLA, the ecosystem accelerator for life sciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors.
Shelly is a consumer tech expert and leads the Palmer Group ; comments on Fox 5 in NYC, CNN, and CNBC; writes a weekly column in Advertising Age; composes music; and he’s a Renaissance Man who’s a generous sharer of knowledge with a great sense of humor and humanity. But it’s not necessarily useful for everything.
Operating independently within the AstraZeneca group, Evinova offers established digital technology solutions globally, aiming to optimize clinical trial design and delivery. The company will supply solutions to AstraZeneca while extending services to pharma, biotech companies, and clinical research organizations.
With offices in Dallas, Houston, and Austin, GPG Ventures invests nationally in biotech, digital health, medtech, consumer health, and general B2B tech. AI pioneer Andrew Ng launched AI Fund in 2018 with $176 million from top-tier firms such as Greylock, NEA, Sequoia, and Softbank Group.
Our unique value-add approach to global venture and growth investment, including our strategic partnership with Boston Consulting Group (BCG), places founders and management teams front-and-center, surrounding them with resources they need to transform large markets through innovation and customer-focused solutions.”
Bilateral partnerships of this nature not only bolster our members’ businesses on the international stage, but also spotlight the robust offerings of our local ecosystem to enterprises from other growing biotech regions such as Florida,” commented Benoit Larose, CEO of BIOQuébec. Preferential registration rates for all partnered events.
Now a group of U.S. According to a press release published in Fierce Biotech Research , researchers from the University of Michigan and several UK and U.S. Drug manufacturers may be making better insulin delivery systems to combat hypoglycemia, but they haven’t yet been able to eliminate the chance that a low can happen.
Digital twins enable TwinRCTs, highly powered clinical trials with smaller control groups, allowing more patients to receive experimental treatment. The participant’s digital twin forecasts their health outcomes under placebo, regardless of their actual assignment.
“This investment provides us with the resources to further advance our platform and expand our reach to additional pharma, CRO, and biotech companies in Europe and the U.S., A recent Deloitte study estimates the average cost of developing a single new drug at $2.3 billion in 2022, with an average 7.1-year year deployment time.
Collaborations between AI vendors and biotech/pharma companies over the last five years are worth more than $45 billion , according to a recent report from Accenture. Drummond Group unveiled FHIR Client Certification Program , which will enter its pilot phase on Oct. HCPLAN also added the advocacy group Accountable for Health.
Hood Medicine & PathCheck Foundation recently participated in a panel discussion on digital vaccines with Bhargav Sri Prakash , Founder & CEO of FriendsLearn , a biotech firm that pioneered the technology. She directs the research division and communications group at Hood Medicine.
We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Riccardo Butta, President of the Americas at Stevanato Group In 2024, we can expect progress around men’s health, specifically in prostate cancer.
According to a Fierce Biotech report on Tresiba, Novo’s resubmission of Tresiba could backfire for a couple of reasons, say analysts. First, only a small group of employees has actually seen the new safety data. If given the green light this time around, the basal insulin would be sold in the U.S.
The Connected Health Conference also promises an emphasis on the Life Sciences/BioTech and Digital Health, with sessions like the Fireside Chat on Pharma and Digital Health and Transforming the Life Sciences through Digital Health. Carrie Nixon. Carrie Nixon, Esq.
A report from the Alexander Group found that 45% of healthcare companies exceeded their revenue growth expectations in 2022 , and 80% are experiencing growth in general. The silver lining: Healthcare is the leading sector, though most funds are going to biotech. Funding has consistently been under $30 billion per month since July 2022.
We are thrilled to enter into this collaboration and license agreement and to continue our work with Dr. Nir-Paz, Dr. Hazan, and the impressive group of phage scientists at Hebrew University and Hadassah Medical Center. Contacts Adaptive Phage Therapeutics Investor Relations: Gilmartin Group, LLC.:
Software in biotech is in the same place as the pipette, but even more so. Metadata defines “comparison groups” — control vs. protocol, pre- vs. post-treatment, one demographic vs. another, responders vs. non-responders, etc. — whatever groupings are relevant can be used to drive visualizations.
Founded in 2015 and headquartered in New York, m+a offers full-service capabilities to a diverse group of blue-chip pharma, biotech, and digital health companies across a range of therapeutic categories, including rare diseases, mental health, oncology, CNS, dermatology, and more. Terms of the transaction were not disclosed.
We plan to gather these stakeholders at the upcoming Huntington Study Group conference this November 3-5 in Tampa, FL, to develop next steps. However, BJ and I cannot do this ourselves, and will need the help from all other HD stakeholders to get this done. Watch his TEDx here and follow him on Instagram here.
Medtronic said the company will be rolled into its Diabetes Group to improve its diabetes management capabilities by adding Nutrino's comprehensive food database, food analysis system and nutrition-science expertise. EBD Group “The Nutrino team is passionate about personalized nutrition data services and technologies.
Parker Health an innovative biotech company for electronic health records, hospital developer & management, and subscription-based health services, today announced that it has secured $25 million in Series A funding led by Bias Capital, a multisector and multi-stage angel syndicate, joined in this round by L’PAJ Ventures, CGT Capital Group, and (..)
In addition to creating this specialized group with a deep understanding of these technologies, the FDA plans to turn the actual medical device regulatory framework on its head. For example, at one time San Antonio and Austin, Texas had more than 200 biotech startups.
Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. Evinova is a health-tech business within the AstraZeneca Group.
The bar chart shows that PhRMA (the advocacy group for the pharmaceutical industry), Blue Cross & Blue Shield Association, the American Hospital Association, and the American Medical Association (representing physicians) were four of the ten highest spending lobbyers in 2018.
This round of financing will enable BrainTale to enter a new phase in its development,” states Sébastien Couvet, head of the MACSF Group’s e-health portfolio. Today, the company has gathered €4.5 Visit: www.capitalgrandest.eu
Since our inception in 2022, ClavystBio has committed over US$220m to biotech, diagnostics, and digital health companies, as well as early-stage VC funds. With these resources, Automera is well positioned to deploy our AUTAC platform toward the development of potentially transformative therapies.”
Sharpless is a proponent of big data and previously founded two biotech companies. It was announced on March 11 that he will be replaced by Norman Sharpless, director of the National Cancer Institute (NCI) in Maryland. CMS Publishes New National Health Expenditures Data.
The company's backers include Norwest Venture Partners, a well-known venture and growth equity firm that manages nearly $10 billion in capital based in Palo Alto, Calif; Compound, a seed-fund based out of New York City; and Qumra Capital, a leading Israeli late-stage venture capital group.
Working group details + housekeeping items. SPM member Michael Mittleman: can we get some veteran representation on the working group on this? Groups outside VA are first line triage for many vets with trauma issues. Big tech community, McGuire VA, Virginia Biotech Park, RVAtech (tech council), VCU Med.
As Sean Salmon, the President of the Diabetes Group at Medtronic puts it: “This acquisition is an ideal strategic fit for Medtronic as we further simplify diabetes management and improve outcomes by optimizing dosing decisions for the large number of people using multiple daily injections (MDI). Keys to Medtronic InPen Success.
Networking Events and Receptions: Various organizations, companies, and groups host receptions, dinners, and networking events. This unparalleled gathering of healthcare and biotech leaders showcases the enduring power of collaboration and innovation, shaping the future of healthcare.
In Italy, WeDoctor has partnered with the Humanitas Group, one of the largest private healthcare groups in Italy. In Spain, WeDoctor has partnered with the Quirónsalud Group, one of the largest private healthcare groups in Spain. JD Health is an online healthcare platform that is part of the JD.com Group.
Still, fewer than 10% of that group do so, according to the researchers — so the ability to predict up to six-year cancer risk from a single scan could help improve current diagnosis rates. Even as venture capital in healthcare languishes, we see bright spots specific to the growing intersection of biotech and computation.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content